Privi Speciality Chemicals LtdNSE: PRIVISCL
Open the Privi Speciality Chemicals Ltd page
Follow Privi Speciality Chemicals LtdFree account. Get a note when Privi Speciality Chemicals Ltd files.
Q1 FY27 results analysis · July 31, 2026

Privi Speciality Chemicals Ltd (PRIVISCL) Q1 FY27 Results Analysis: PAT Surges 36%, Margin Misses Guidance

+36.0%PAT year on year, Rs. 84.21 Cr
Cofacto ResearchPublished July 31, 20262 min readNeutral read
Quick summary

Privi Speciality Chemicals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 666.22 Cr (+19.22% YoY) and PAT growth of +35.97% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 30, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 666.22 Cr (+19.22% YoY)
PAT (Q1)Rs. 84.21 Cr (+35.97% YoY)
EBITDA margin22.86% (-77 bps YoY)
EPS (Q1)Rs. 21.56 (+36.03% YoY)
Market capRs. 13,957.10 Cr
CMPRs. 3,573.00

Quarter Snapshot

Privi Speciality Chemicals reported 19.22% YoY revenue growth to Rs.666.22 Cr, with PAT attributable to owners surging 35.97% YoY. However, consolidated EBITDA margin of 22.86% missed the guided 24-26% band due to raw material cost pressure. The subsidiary drag virtually disappeared, confirming the PRIGIV JV's profitability milestone, while forex gains boosted other income.

Key Investment Insights

Key Positives

  • Revenue grew 19.22% YoY to Rs.666.22 Cr.
  • PAT attributable to owners grew 35.97% YoY to Rs.84.21 Cr.
  • Subsidiary drag narrowed from Rs.6.76 Cr to Rs.0.06 Cr, with PRIGIV turning profitable.
  • Finance costs declined 29.23% YoY to Rs.16.74 Cr.
  • Standalone EBITDA margin of 24.24% remained within the 24-26% guided band.

Risk Factors

  • Consolidated EBITDA margin of 22.86% fell below the guided 24-26% band.
  • Raw material cost pressure: cost of materials as % of revenue rose 485 bps YoY to 59.57%.
  • Revenue declined 7.66% sequentially, though Q1 is seasonally weak.
  • Elevated other income from forex gains is volatile and may not be sustainable.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.